Joel Whitfield

3.8k total citations · 2 hit papers
30 papers, 3.1k citations indexed

About

Joel Whitfield is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Joel Whitfield has authored 30 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 12 papers in Immunology and 10 papers in Oncology. Recurrent topics in Joel Whitfield's work include Hematopoietic Stem Cell Transplantation (11 papers), Immunotherapy and Immune Responses (8 papers) and Acute Myeloid Leukemia Research (6 papers). Joel Whitfield is often cited by papers focused on Hematopoietic Stem Cell Transplantation (11 papers), Immunotherapy and Immune Responses (8 papers) and Acute Myeloid Leukemia Research (6 papers). Joel Whitfield collaborates with scholars based in United States, China and Japan. Joel Whitfield's co-authors include Jong‐Hwan Park, Gabriel Núñez, Amal O. Amer, Thirumala‐Devi Kanneganti, Luigi Franchi, Mathilde Body–Malapel, Dov L. Boros, Peter Vandenabeele, Winfried Barchet and Nesrin Özören and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Blood.

In The Last Decade

Joel Whitfield

30 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3

2006 935 citations Thirumala‐Devi Kanneganti, Nesrin Özören et al. Nature profile →
Critical Role for Cryopyrin/Nalp3 in Activation of Caspase-1 in Response to Viral Infection and Double-stranded RNA

2006 568 citations Thirumala‐Devi Kanneganti, Mathilde Body–Malapel et al. Journal of Biological Chemistry profile →

Peers

Joel Whitfield

IMMUN

HEMAT

ONCOL

EPIDE

Walter Ferlin Switzerland

Tomohiro Yoshimoto Japan

Rudolf H. Zubler Switzerland

Shahla Abdollahi‐Roodsaz Netherlands

Jacqueline McBride United States

Sean Stevens United States

Morten Hanefeld Dziegiel Denmark

Mathias G. Lichtenheld United States

Thomas Hehlgans Germany

Maria Leite‐de‐Moraes France

Walter Ferlin Switzerland

Joel Whitfield

2.0k ×1.1

IMMUN

579 ×0.4

465 ×0.8

HEMAT

707 ×1.3

ONCOL

339 ×1.2

EPIDE

Citations per year, relative to Joel Whitfield Joel Whitfield (= 1×) peers Walter Ferlin

Countries citing papers authored by Joel Whitfield

Since Specialization

Citations

This map shows the geographic impact of Joel Whitfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Whitfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Whitfield more than expected).

Fields of papers citing papers by Joel Whitfield

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel Whitfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Whitfield. The network helps show where Joel Whitfield may publish in the future.

Co-authorship network of co-authors of Joel Whitfield

This figure shows the co-authorship network connecting the top 25 collaborators of Joel Whitfield. A scholar is included among the top collaborators of Joel Whitfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel Whitfield. Joel Whitfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Jing, Yangyang Hu, Alireza Hassani Najafabadi, et al.. (2022). Efficacy of an ALDH peptide-based dendritic cell vaccine targeting cancer stem cells. Cancer Immunology Immunotherapy. 71(8). 1959–1973. 19 indexed citations

Zhao, Lili, Kathryn A. Eaton, Sharon L. Ho, et al.. (2020). Gut Microbiota Modulate CD8 T Cell Responses to Influence Colitis-Associated Tumorigenesis. Cell Reports. 31(1). 107471–107471. 135 indexed citations

Hu, Yangyang, Lin Lü, Yang Xia, et al.. (2016). Therapeutic Efficacy of Cancer Stem Cell Vaccines in the Adjuvant Setting. Cancer Research. 76(16). 4661–4672. 67 indexed citations

Choi, Sung Won, Erin Gatza, Guoqing Hou, et al.. (2014). Histone deacetylase inhibition regulates inflammation and enhances Tregs after allogeneic hematopoietic cell transplantation in humans. Blood. 125(5). 815–819. 86 indexed citations

Paczesny, Sophie, Thomas Braun, Mark Vander Lugt, et al.. (2011). A Three Biomarker Panel at Days 7 and 14 Can Predict Development of Grade II-IV Acute Graft-Versus-Host Disease. Biology of Blood and Marrow Transplantation. 17(2). S167–S167. 5 indexed citations

Paczesny, Sophie, John E. Levine, Jason M. Hogan, et al.. (2009). Elafin is a Biomarker of Graft Versus Host Disease of the Skin. Biology of Blood and Marrow Transplantation. 15(2). 13–14. 5 indexed citations

Paczesny, Sophie, Oleg I. Krijanovski, Thomas Braun, et al.. (2008). A biomarker panel for acute graft-versus-host disease. Blood. 113(2). 273–278. 290 indexed citations

Teitz‐Tennenbaum, Seagal, Qiao Li, Ryuji Okuyama, et al.. (2008). Mechanisms Involved in Radiation Enhancement of Intratumoral Dendritic Cell Therapy. Journal of Immunotherapy. 31(4). 345–358. 72 indexed citations

Kitko, Carrie L., Sophie Paczesny, Gregory A. Yanik, et al.. (2008). Plasma Elevations of Tumor Necrosis Factor-Receptor-1 at Day 7 Postallogeneic Transplant Correlate with Graft-versus-Host Disease Severity and Overall Survival in Pediatric Patients. Biology of Blood and Marrow Transplantation. 14(7). 759–765. 33 indexed citations

10.

Paczesny, Sophie, John E. Levine, Jason M. Hogan, et al.. (2008). Elafin Is a Biomarker of Graft Versus Host Disease of the Skin. Blood. 112(11). 716–716. 1 indexed citations

11.

Redman, Bruce G., Alfred E. Chang, Joel Whitfield, et al.. (2008). Phase Ib Trial Assessing Autologous, Tumor-pulsed Dendritic Cells as a Vaccine Administered With or Without IL-2 in Patients With Metastatic Melanoma. Journal of Immunotherapy. 31(6). 591–598. 67 indexed citations

12.

Choi, Sung Won, Carrie L. Kitko, Thomas Braun, et al.. (2008). Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival. Blood. 112(4). 1539–1542. 109 indexed citations

13.

Kroon, Hidde M., Qiao Li, Seagal Teitz‐Tennenbaum, et al.. (2007). 4-1BB Costimulation of Effector T Cells for Adoptive Immunotherapy of Cancer: Involvement of Bcl Gene Family Members. Journal of Immunotherapy. 30(4). 406–416. 11 indexed citations

14.

Kanneganti, Thirumala‐Devi, Mathilde Body–Malapel, Amal O. Amer, et al.. (2006). Critical Role for Cryopyrin/Nalp3 in Activation of Caspase-1 in Response to Viral Infection and Double-stranded RNA. Journal of Biological Chemistry. 281(48). 36560–36568. 568 indexed citations breakdown →

15.

Kanneganti, Thirumala‐Devi, Nesrin Özören, Mathilde Body–Malapel, et al.. (2006). Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature. 440(7081). 233–236. 935 indexed citations breakdown →

16.

Qiao, Li, Amelia Grover, Jiyun Yu, et al.. (2005). Simultaneous Targeting of CD3 on T Cells and CD40 on B or Dendritic Cells Augments the Antitumor Reactivity of Tumor-Primed Lymph Node Cells. The Journal of Immunology. 175(3). 1424–1432. 34 indexed citations

17.

Uberti, Joseph P., Lois Ayash, Voravit Ratanatharathorn, et al.. (2005). Pilot Trial on the Use of Etanercept and Methylprednisolone as Primary Treatment for Acute Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 11(9). 680–687. 63 indexed citations

18.

Tabakoff, Boris, Anders Helander, Katherine M. Conigrave, et al.. (2001). WHO/ISBRA Study on State and Trait Markers in Alcoholism. Alcoholism Clinical and Experimental Research. 25(s1). 99S–103S. 8 indexed citations

19.

Boros, Dov L. & Joel Whitfield. (1999). Enhanced Th1 and Dampened Th2 Responses Synergize To Inhibit Acute Granulomatous and Fibrotic Responses in Murine Schistosomiasis Mansoni. Infection and Immunity. 67(3). 1187–1193. 32 indexed citations

20.

Kaplan, Mark H., Joel Whitfield, Dov L. Boros, & Michael J. Grusby. (1998). Th2 Cells Are Required for the Schistosoma mansoni Egg-Induced Granulomatous Response. The Journal of Immunology. 160(4). 1850–1856. 196 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact